Transcription and pre-mRNA splicing are coordinated temporally and spatially, and both processes can influence each other. In particular, control of transcriptional elongation by RNA polymerase II has proved to be important for alternative splicing regulation. In this report we demonstrate that the efficiency of exon recognition by the splicing machinery is crucial for the elongation control. Alternative splicing of the fibronectin extra domain I (EDI) is because the polypyrimidine tract of its 3-splice site occurs suboptimal. By mutating the polypyrimidine tract of EDI in two different positions, individually or in combination, and by disrupting its exonic splicing silencer, we managed to generate minigenes with increasing degrees of exon recognition. Improvement of exon recognition is evidenced by independence from the splicing regulator SF2/ASF for inclusion. The mutated minigenes were used to transfect human cells in culture and study the responsiveness of EDI alternative splicing to activation or inhibition of pol II elongation. Our results revealed that responsiveness of exon skipping to elongation is inversely proportional to 3-splice site strength, which means that the better the alternative exon is recognized by the splicing machinery, the less its degree of inclusion is affected by transcriptional elongation.Most human gene transcripts are alternatively spliced generating several different mRNAs that increase protein diversity (1). cis-Acting sequences and trans-acting factors regulate splicing. The sequences involved are mainly the 5Ј-splice site (5Ј-ss) 1 or donor site, the 3Ј-splice site (3Ј-ss) or acceptor site that includes a pyrimidine-rich region called the polypyrimidine tract (PPT), and the branch point, located 18 -40 nucleotides upstream of the 3Ј-ss. In metazoans, the PPT is essential for efficient branch point utilization and 3Ј-ss recognition (2). On the other hand, protein factors can act on regulatory sequences. When alternative splicing exists, the choice between the alternative sites depends on the relative quality of the constitutive signals. In addition, regulatory proteins can shift this balance and favor one site usage to the detriment of the other. This implies the presence of complex regulatory mechanisms.Reactions involved in pre-mRNA processing such as capping, splicing, and 3Ј-end processing/polyadenylation are closely coupled to RNA polymerase II (pol II) transcription and can modulate each other, adding to the intricacy of these events (for reviews see Refs. 3-7). For example, we have demonstrated that promoter identity can affect alternative splicing (8, 9). This could be achieved by the recruitment of splicing factors and/or by modulating pol II elongation rate. Factors that increase elongation, such as certain transcriptional activators, stimulate skipping of the fibronectin (FN) EDI exon, whereas treatments with drugs that inhibit elongation like 5,6-dichloro-1--D-ribofuranosylbenzimidazole (DRB), favor exon inclusion (10 -12). More recent and direct evidence supports ...